ArticleLancet (London, England)2020
SARS-CoV-2 seroprevalence in COVID-19 hotspots.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
68 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Key questions for modelling COVID-19 exit strategies.Proceedings. Biological sciences · 2020Pooled it
- Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown.Scientific reports · 2021Trial
- SARS-CoV-2 seroprevalence in Barcelona and Catalonia (Spain) after the 2020 lockdown.Scientific reports · 2026Article
- Seroprevalence of SARS-CoV-2 antibodies in Ethiopia: findings from the 2022 national population-based survey (second round).BMC infectious diseases · 2025Article
- Knowledge attitude practice among oncologists and health care workers during COVID19 pandemic.Journal of the Egyptian National Cancer Institute · 2024Article
- Maternal Seroprevalence and Placental Transfer of COVID-19 Antibodies in Pregnancy: A Hospital-Based Study.Cureus · 2023Article
- Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020-2021 population-based household survey.PLOS global public health · 2023Article
- Directly immersible silicon photonic probes: Application to rapid SARS-CoV-2 serological testing.Biosensors & bioelectronics · 2022Article
- Seroprevalence of SARS-CoV-2 on health professionals via Bayesian estimation: a Brazilian case study before and after vaccines.Acta tropica · 2022Article
- COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study.BMJ open · 2022Article
- Prevalence of SARS-CoV-2 antibodies and risk factors in the pandemic epicentre of Catalonia.Scientific reports · 2022Article
- Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.The Journal of infection · 2022Article
- Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022Article
- Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area.Annals of epidemiology · 2022Article
- Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies.Genes & diseases · 2022Article
- The Heterogeneous Severity of COVID-19 in African Countries: A Modeling Approach.Bulletin of mathematical biology · 2022Article
- Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia.PloS one · 2022Observational
- Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China.Frontiers in public health · 2022Article
- Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later.PloS one · 2022Article
- SARS-CoV-2 Seroprevalence in Western Romania, March to June 2021.Medicina (Kaunas, Lithuania) · 2021Article
8 more citing papers are in PubMed but not listed here.
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.